VITASPRING BIOMEDICAL CO., LTD. (VSBC) Total liabilities 2017–2026
VITASPRING BIOMEDICAL CO., LTD. (VSBC) total liabilities at each fiscal year-end, per SEC filings.
$4.4MFY2026 · since FY2017: $4,555 → $4.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $4.4M | +10.3% |
| FY2025 | $4.0M | +15.5% |
| FY2024 | $3.5M | +10.3% |
| FY2023 | $3.2M | +56.1% |
| FY2022 | $2.0M | +2078.3% |
| FY2021 | $93,034 | -3.5% |
| FY2020 | $96,364 | +743.0% |
| FY2019 | $11,431 | -11.3% |
| FY2018 | $12,891 | +183.0% |
| FY2017 | $4,555 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice